We are live on ! Find out more
PTCT icon

PTC Therapeutics
PTCT

129 hedge funds and large institutions have $715M invested in PTC Therapeutics in 2017 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 53 increasing their positions, 32 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

123% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 13

66% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 32

16% more capital invested

Capital invested by funds: $615M → $715M (+$101M)

13% more funds holding

Funds holding: 114 → 129 (+15)

5.05% more ownership

Funds ownership: 81.32% → 86.37% (+5.1%)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

52% less call options, than puts

Call options by funds: $41.2M | Put options by funds: $86.1M

Holders
129
Holders Change
+15
Holders Change %
+13.16%
% of All Funds
3.22%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
29
Increased
53
Reduced
32
Closed
13
Calls
$41.2M
Puts
$86.1M
Net Calls
-$44.9M
Net Calls Change
-$54.1M

Top Buyers

Rank Fund Capital Flow
1
SCM
Scopia Capital Management
New York
+$23.4M
2
DAM
DLD Asset Management
New York
+$12M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$11.1M
4
NI
Numeric Investors
Massachusetts
+$9.22M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$8.89M

Top Sellers

Rank Fund Capital Flow
1
FCM
Frontier Capital Management
Massachusetts
-$20.8M
2
GPP
Great Point Partners
Connecticut
-$15.7M
3
Morgan Stanley
Morgan Stanley
New York
-$9.26M
4
CCM
Camber Capital Management
Massachusetts
-$9.16M
5
BC
Boxer Capital
California
-$8.81M
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
51
Eventide Asset Management
Massachusetts
$1.36M +$1.34M +68,200 New
WVP
52
Worth Venture Partners
New Jersey
$1.32M +$1.3M +66,196 New
Swiss National Bank
53
Swiss National Bank
Switzerland
$1.31M +$176K +9,000 +16%
California State Teachers Retirement System (CalSTRS)
54
California State Teachers Retirement System (CalSTRS)
California
$1.28M +$100K +5,119 +9%
CG
55
Cutler Group
California
$1.28M +$1.05M +53,570 +524%
UBS Group
56
UBS Group
Switzerland
$1.27M +$710K +36,277 +132%
TA
57
Teachers Advisors
New York
$1.27M +$39K +1,994 +3%
MWNA
58
Marshall Wace North America
New York
$1.24M +$1.21M +61,745 New
Deutsche Bank
59
Deutsche Bank
Germany
$1.2M -$1.04M -53,324 -47%
CS
60
Candriam SCA
Luxembourg
$1.2M +$1.17M +60,000 New
CS
61
Credit Suisse
Switzerland
$1.15M +$234K +11,975 +26%
Wells Fargo
62
Wells Fargo
California
$1.06M -$14.3K -732 -1%
New York State Common Retirement Fund
63
New York State Common Retirement Fund
New York
$1.06M +$41.5K +2,122 +4%
Prudential Financial
64
Prudential Financial
New Jersey
$1.02M +$787K +40,212 +365%
MCM
65
Moore Capital Management
New York
$1M -$979K -50,000 -50%
AllianceBernstein
66
AllianceBernstein
Tennessee
$987K – – –
CM
67
Crestline Management
Texas
$955K -$980K -50,071 -51%
ARTA
68
A.R.T. Advisors
New York
$901K +$882K +45,063 New
RhumbLine Advisers
69
RhumbLine Advisers
Massachusetts
$842K +$65.3K +3,335 +9%
SG Americas Securities
70
SG Americas Securities
New York
$834K +$816K +41,694 New
AA
71
ALPS Advisors
Colorado
$816K +$187K +9,571 +31%
Citigroup
72
Citigroup
New York
$810K -$107K -5,470 -12%
California Public Employees Retirement System
73
California Public Employees Retirement System
California
$698K +$301K +15,378 +79%
Simplex Trading
74
Simplex Trading
Illinois
$681K +$135K +6,883 +25%
Barclays
75
Barclays
United Kingdom
$622K -$1.17M -59,881 -66%
1 2
3
4 5

PTCT Hedge Fund Activity: Q3 2017 in Review

129 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in PTC Therapeutics (PTCT) for Q3 2017, worth a combined $715M — up 16% from $615M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new PTCT positions and 13 closed out — a net gain of 16 holders — while 53 added to existing stakes and 32 trimmed.

The largest buyer was Scopia Capital Management, opening a new position worth an estimated $23.4M. The largest seller was Frontier Capital Management, cutting an estimated $20.8M.

  • 129 institutional investors held PTC Therapeutics (PTCT) as of Q3 2017, up from 114 in Q2 2017.
  • Funds reported $715M of PTC Therapeutics stock for Q3 2017, up 16% quarter-over-quarter.
  • 29 funds opened new PTC Therapeutics positions in Q3 2017 and 13 closed out, a net change of +16 holders.
  • The largest PTC Therapeutics buyer in Q3 2017 was Scopia Capital Management, an estimated $23.4M added.
  • The largest PTC Therapeutics seller in Q3 2017 was Frontier Capital Management, an estimated $20.8M sold.

Based on aggregated 13F filings for Q3 2017.